Vaccination greatly reduces the probability of experiencing severe COVID-19 in both variants. Adults between the ages of 40 to 59 years saw the most significant reduction in risk when compared to individuals in other age categories.
Matthew Gavidia
Advertisement
Articles by Matthew Gavidia
Michael E. Chernew, PhD, co-editor-in-chief of The American Journal of Managed Care®, discussed cost and sustainability issues specific to commercial insurance, Medicare, and Medicaid at the National Alliance 2021 Annual Forum held in a hybrid format in Washington, DC.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Drug Topics
1
FDA Releases Biosimilar Guidance Pushing to Streamline Development
2
COVID-19 Vaccination Benefits Patients With Systemic Lupus Erythematosus
3
Q&A: Why Community Pharmacies are Displeased with the MDPNP | NCPA 2025
4
Pharmacies Should Prioritize Medicare Transaction Facilitator Enrollment | NCPA 2025
5
